Pazopanib in Treating Patients With Advanced Thyroid Cancer

Share this content:

Pazopanib in Treating Patients With Advanced Thyroid Cancer

Sponsors and Collaborators
Mayo Clinic
National Cancer Institute (NCI)

Contacts
United States, Arizona
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States, 85259-5499
Contact: Clinical Trials Office - All Mayo Clinic Locations     507-538-7623        

United States, Colorado
University of Colorado Cancer Center at UC Health Sciences Center Recruiting Aurora, Colorado, United States, 80045 Contact: Clinical Trials Office - University of Colorado Cancer Center     720-848-0650        

United States, District of Columbia
Howard University Cancer Center, Washington, District of Columbia, United States, 20060 Contact: Clinical Trials Office - Howard University Cancer Center     202-806-9122        

United States, Florida
Mayo Clinic - Jacksonville Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Office - All Mayo Clinic Locations     507-538-7623  

United States, Iowa
Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States, 52242-1002 Contact: Cancer Information Service     800-237-1225        

United States, Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States, 48201-1379 Contact: Clinical Trials Office - Barbara Ann Karmanos Cancer Institute     313-576-9363

United States, Minnesota
Minnesota Oncology Hematology, PA - Minneapolis, Minneapolis, Minnesota, United States, 55407 Contact: Patrick J. Flynn, MD     612-863-8585        
Mayo Clinic Cancer Center,  Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Office - All Mayo Clinic Locations     507-538-7623  

United States, Missouri
Center for Cancer Care and Research, Saint Louis, Missouri, United States, 63141 Contact: John R. Eckardt, MD     314-628-1210     jeckardt@tcccr.com    
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, Saint Louis, Missouri, United States, 63110 Contact: Jeffrey F. Moley, MD     314-747-0064        

United States, Wisconsin
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, Wisconsin, United States, 53792-6164 Contact: Clinical Trials Office - University of Wisconsin Paul P. Carbo     608-262-5223    

Australia, Western Australia
Sir Charles Gairdner Hospital - Nedlands, Perth, Western Australia, Australia, 6009 Contact: Michael Millward, MD     61-8-9346-3823     millward@cyllene.uwa.edu.au    

China
Prince of Wales Hospital, Hong Kong, China Contact: Brigette Ma, MD     852-2632-2118        

Korea, Republic of
Yonsei Cancer Center at Yonsei University Medical Center
Seoul, Korea, Republic of, 120-752 Contact: Joong B. Ahn, MD     82-2-2228-8134  

Singapore
Cancer Institute at National University Hospital, Singapore, Singapore, 119074 Contact: Boon C. Goh, MD     65-6772-4617
Johns Hopkins Singapore International Medical Centre, Singapore, Singapore, 308433 Contact: Alex Y. Chang, MD     65-6880-2222     alexchang@imc.jhmi.edu    
National Cancer Centre - Singapore, Singapore, Singapore, 169610 Contact: Darren L. Wan Teck, MD     65-6436-8174     dmolwt@nccs.com.sg     Taiwan National Taiwan University Hospital, Taipei, Taiwan, 10016 Contact: Chia-Chi Lin, MD, PhD     886-2-2312-3456 ext. 67680


Principal Investigators

Keith C. Bible, MD, PhD, Mayo Clinic

ClinicalTrials.gov Identifier
NCT0062584

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs